Skip to main content

IDRC extends effort to address antimicrobial resistance to protect global health and food security

 
Antimicrobial resistance in animals remains a growing problem that threatens our ability to effectively treat bacterial infections in humans and animals. It endangers modern human and veterinary medicine and undermines the safety of our food and environment.
Vaccine researcher sits at a desk
IDRC/Bartay

To find solutions to this problem, IDRC has launched the second phase of Innovative Veterinary Solutions for Antimicrobial Resistance (Innovet-AMR 2.0), a partnership between IDRC and the Government of the United Kingdom. Together, they will fund research to minimize the development of antimicrobial resistance in ruminants and aquaculture production. 

InnoVet-AMR 2.0 will support the prudent and reduced use of antimicrobials, and the development and uptake of innovative veterinary products in low- and middle-income countries.

Livestock and aquaculture keepers in low- and middle-income countries are highly affected by the increase of infectious disease outbreaks and loss in livestock productivity, which ultimately endanger food security and disrupt international trade. The contamination of animal products, and the wider environment, with antimicrobial-resistant bacteria is also a risk factor for humans, animals and the environment.    

The CAD30-million partnership spans four years and aims to develop alternatives to antimicrobials for farmers to treat their animals. The initiative features 15 research projects across Asia, Africa and Latin America.  

Innovet-AMR recently hosted their launch event with over 60 participants to collaborate on offering alternatives to antimicrobials in agriculture.  

Learn more about the Innovet-AMR initiative.